Review Article

Association between the MMP-1-1607 1G/2G Polymorphism and Osteoarthritis Risk: A Systematic Review and Meta-Analysis

Table 1

Characteristics of the eligible studies included in the meta-analysis.

AuthorYearCountryEthnicityOA siteSampleGenotyping methodSurgeryDesignSample sizeGender (M/F)Mean ageNOS
Total sizeCaseControlCaseControlCaseControl

Barlas2009TurkeyCaucasianKeen OABloodPCR-RFLPNoHCC2411578436/12125/5941–86; 41–75; 52.36.96
Planello2011BrazilCaucasianTMJ OABuccal cellPCR-RLFPNoPCC23211511714/10115/1027
Abd-Allah2012EgyptCaucasianKeen OABloodPCR-RLFPNoHCC20010010040/6045/5536–66; 33–67; 6
Lepetsos2014GreekCaucasianKeen OABloodPCR-RLFPYesHCC29415513933/12242/978
Luo2015ChinaAsianTMJBuccal cellHRMAYesPCC391206185NA26/15916–75; 16–71; 6
Yang2015ChinaAsianKeen OABloodPCR-RFLPYesPCC41420720753/15453/1548
Geng2018ChinaAsianKeen OABloodPCR-RFLPNoPCC707306401164/142199/2027

OA: osteoarthritis; TMJ: temporomandibular joint; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; HRMA: high-resolution melting assay; HCC: hospital-based case-control study; PCC: population-based case-control study; NOS: Newcastle-Ottawa Scale.